Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.

[1]  A. Ullrich,et al.  Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. , 2015, Cell metabolism.

[2]  M. Mace,et al.  Key role of the kidney in the regulation of fibroblast growth factor 23. , 2015, Kidney international.

[3]  M. Wolf,et al.  Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production , 2015, Kidney international.

[4]  M. Wolf,et al.  Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease , 2014, Current opinion in nephrology and hypertension.

[5]  H. Hense,et al.  Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: a prospective, case-cohort study. , 2014, The Journal of clinical endocrinology and metabolism.

[6]  A. Go,et al.  Fibroblast growth factor-23 and cardiovascular events in CKD. , 2014, Journal of the American Society of Nephrology : JASN.

[7]  E. Giovannucci,et al.  Association of Low Serum 25-Hydroxyvitamin D Levels and Sepsis in the Critically Ill , 2014, Critical care medicine.

[8]  I. Koulouridis,et al.  World incidence of AKI: a meta-analysis. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[9]  A. Goulart,et al.  Decreased parathyroid hormone levels despite persistent hypocalcemia in patients with kidney failure recovering from septic shock. , 2013, Endocrine, metabolic & immune disorders drug targets.

[10]  D. Leaf,et al.  Plasma FGF23 levels increase rapidly after acute kidney injury , 2013, Kidney international.

[11]  J. Bacchetta,et al.  Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25‐dihydroxyvitamin D in human monocytes , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  A. Khwaja.  KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[13]  Herbert Chase,et al.  FGF-23 levels in patients with AKI and risk of adverse outcomes. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[14]  B. Kestenbaum,et al.  Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). , 2012, Journal of the American College of Cardiology.

[15]  Norbert Lameire,et al.  Notice , 2012, Kidney International Supplements.

[16]  A. Go,et al.  FGF23 induces left ventricular hypertrophy. , 2011, The Journal of clinical investigation.

[17]  Frederick G. Strathmann,et al.  Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. , 2011, Clinical chemistry.

[18]  M. Hewison.  Antibacterial effects of vitamin D , 2011, Nature Reviews Endocrinology.

[19]  Jiang He,et al.  Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. , 2011, JAMA.

[20]  Chi-yuan Hsu,et al.  FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study , 2011, Annals of intensive care.

[21]  Huiliang Xie,et al.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. , 2011, Kidney international.

[22]  C. Camargo,et al.  Vitamin D insufficiency and sepsis severity in emergency department patients with suspected infection. , 2011, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[23]  John Cunningham,et al.  Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[24]  E. Giovannucci,et al.  Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill* , 2011, Critical care medicine.

[25]  Jeremiah R. Brown,et al.  Cardiac surgery-associated acute kidney injury: a comparison of two consensus criteria. , 2010, The Annals of thoracic surgery.

[26]  T. Shimada,et al.  Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. , 2010, Kidney international.

[27]  D. Leaf,et al.  Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  G. Duda,et al.  FGF23 is a putative marker for bone healing and regeneration , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[29]  S. Waikar,et al.  Creatinine kinetics and the definition of acute kidney injury. , 2009, Journal of the American Society of Nephrology : JASN.

[30]  J. Mora,et al.  Vitamin effects on the immune system: vitamins A and D take centre stage , 2008, Nature Reviews Immunology.

[31]  L. Guillou,et al.  Determination of the threshold of cardiac troponin I associated with an adverse postoperative outcome after cardiac surgery: a comparative study between coronary artery bypass graft, valve surgery, and combined cardiac surgery , 2007, Critical care.

[32]  J. Pieters.  Faculty Opinions recommendation of Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. , 2006 .

[33]  S. Kato,et al.  Role of the vitamin D receptor in FGF23 action on phosphate metabolism. , 2005, The Biochemical journal.

[34]  R. Henning,et al.  Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. , 2004, Journal of the American Society of Nephrology : JASN.

[35]  L. Bachmann,et al.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. , 2004, Journal of the American Society of Nephrology : JASN.

[36]  M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.

[37]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[38]  D C Angus,et al.  Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. , 1999, American journal of respiratory and critical care medicine.

[39]  J. Rastad,et al.  Circulating ionized calcium and parathyroid hormone levels following coronary artery by-pass surgery. , 1999, Scandinavian journal of clinical and laboratory investigation.

[40]  A. Arieff,et al.  Divalent ion metabolism in patients with acute renal failure: studies on the mechanism of hypocalcemia. , 1974, Kidney international.

[41]  H E de Wardener,et al.  Effect of urinary extracts from salt-loaded man on urinary sodium excretion by the rat. , 1972, Kidney international.

[42]  J. Alpert,et al.  The third universal definition of myocardial infarction , 2013 .

[43]  S. Mundra,et al.  Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis , 2009 .